In vivo, AGER neutralizing antibody significantly inhibited metastasis development in an established mouse model of lung metastasis [8] and silencing AGER using shRNA markedly reduced metastasis to the lung and liver in multiple xenograft and syngeneic breast cancer mouse models [25]. This evidence concerns the gene AGER and breast carcinoma.